{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:30:51Z","timestamp":1780086651475,"version":"3.54.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015068","name":"Universidade de Santiago de Compostela","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015068","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to highlight the major modifications introduced in the FIGO 2023 staging system for endometrial cancer (EC) and their implications for MRI interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This pictorial essay was based on a retrospective review of 27 histologically confirmed cases of endometrial cancer (EC) imaged between 2009 and 2023 at our institution. Cases were selected to represent a broad spectrum of FIGO 2009 and FIGO 2023 stages, emphasizing features with updated staging implications. Inclusion criteria were availability of preoperative pelvic MRI and complete histopathological data, including molecular classification when available. Exclusion criteria included suboptimal image quality or incomplete clinical records. MRI assessments were performed by two radiologists with 25 years of experience in gynecological imaging, respectively. In illustrative examples where inter-reader differences arose, consensus was reached after joint review; however, no formal inter-reader agreement statistics (e.g., kappa values) were calculated, given the descriptive nature of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The revised FIGO 2023 staging incorporates molecular subtypes, refines classification criteria, and improves the prognostic significance of MRI findings in EC staging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The integration of histopathology, molecular markers, and MRI features enhances diagnostic accuracy and treatment planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00261-025-05058-9","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T01:27:43Z","timestamp":1749778063000},"page":"261-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The updated 2023 staging of endometrial cancer: tips for MRI interpretation"],"prefix":"10.1007","volume":"51","author":[{"given":"Diogo Miguel","family":"Machado Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iglesias Casta\u00f1on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Arias Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Escobar Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon Francisco","family":"Ferreira Polli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Herreros Villaraviz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ma\u00f1as Uxo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Nieto Baltar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Nieto Parga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"5058_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijgo.14923","volume":"162","author":"JS Berek","year":"2023","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162:383\u201394. https:\/\/doi.org\/10.1002\/ijgo.14923.","journal-title":"Int J Gynecol Obstet"},{"key":"5058_CR2","unstructured":"American Cancer Society; Union for International Cancer Control (UICC); International Agency for Research on Cancer (IARC). The Cancer Atlas. 3rd ed. Lyon, France: International Agency for Research on Cancer; 2019. Available from: https:\/\/publications.iarc.fr\/Non-Series-Publications\/Other-Non-Series-Publications\/The-Cancer-Atlas-3rd-Edition-2019"},{"key":"5058_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ygyno.2022.02.024","volume":"165","author":"F Siegenthaler","year":"2022","unstructured":"Siegenthaler F, Lindemann K, Epstein E, Rau TT, Nastic D, Ghaderi M, et al. Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification. Gynecol Oncol. 2022;165:230\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2022.02.024.","journal-title":"Gynecol Oncol"},{"key":"5058_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40644-016-0069-1","volume":"16","author":"M Meissnitzer","year":"2016","unstructured":"Meissnitzer M, Forstner R. MRI of endometrium cancer\u2013 how we do it. Cancer Imaging. 2016;16:11. https:\/\/doi.org\/10.1186\/s40644-016-0069-1.","journal-title":"Cancer Imaging"},{"key":"5058_CR5","doi-asserted-by":"publisher","first-page":"113318","DOI":"10.1016\/j.ejca.2023.113318","volume":"193","author":"I Vergote","year":"2023","unstructured":"Vergote I, Matias-Guiu X. New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables! Eur J Cancer. 2023;193:113318. https:\/\/doi.org\/10.1016\/j.ejca.2023.113318.","journal-title":"Eur J Cancer"},{"key":"5058_CR6","doi-asserted-by":"publisher","first-page":"115258","DOI":"10.1016\/j.ejca.2025.115258","volume":"218","author":"Z Li","year":"2025","unstructured":"Li Z, Peng J, Zhang B, Zhao C, Chen Z, Xiao H, Zhang Z, Ma X, Gao F, Xin R, Wang W, Wang S, Tang L, Zhang Y, Kong B, Li L, Yin A. The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma. Eur J Cancer. 2025;218:115258. doi: https:\/\/doi.org\/10.1016\/j.ejca.2025.115258. Epub 2025 Jan 27. PMID: 39893748.","journal-title":"Eur J Cancer"},{"key":"5058_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s00330-018-5515-y","volume":"29","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, et al. Endometrial cancer MRI staging: Updated guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2019;29:792\u2013805. https:\/\/doi.org\/10.1007\/s00330-018-5515-y.","journal-title":"Eur Radiol"},{"key":"5058_CR8","unstructured":"Chikhaoui F, El Ouazzani GI, Ihssane EO, Jamil J, Tabakh H, Siwane A, et al. MRI and endometrial cancer. ECR 2023 EPOS. 2023. Available from: https:\/\/epos.myesr.org\/poster\/esr\/ecr2023\/C-23209."},{"key":"5058_CR9","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.4314\/ahs.v19i4.47","volume":"19","author":"C Dane","year":"2019","unstructured":"Dane C, Bakir S. The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma. Afr Health Sci. 2019;19:3235\u201341. https:\/\/doi.org\/10.4314\/ahs.v19i4.47.","journal-title":"Afr Health Sci."},{"key":"5058_CR10","doi-asserted-by":"publisher","unstructured":"Wang J, Xu P, Yang X, Yu Q, Xu X, Zou G, et al. Association of myometrial invasion with lymphovascular space invasion, lymph node metastasis, recurrence, and overall survival in endometrial cancer: A meta-analysis of 79 studies with 68,870 patients. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.762329.","DOI":"10.3389\/fonc.2021.762329"},{"key":"5058_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/978-1-4939-1884-3_27","volume-title":"Cross-sectional imaging of the abdomen and pelvis: a practical algorithmic approach","author":"K Ganesan","year":"2015","unstructured":"Ganesan K, Morani AC, Marcal LP, Bhosale PR, Elsayes KM. Cross-sectional imaging of the uterus. In: Elsayes KM, editor. Cross-sectional imaging of the abdomen and pelvis: a practical algorithmic approach. New York: Springer; 2015. p. 875\u2013936. https:\/\/doi.org\/10.1007\/978-1-4939-1884-3_27."},{"key":"5058_CR12","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1148\/rg.220070","volume":"42","author":"E Maheshwari","year":"2022","unstructured":"Maheshwari E, Nougaret S, Stein EB, Rauch GM, Hwang KP, Stafford RJ, et al. Update on MRI in evaluation and treatment of endometrial cancer. Radiographics. 2022;42:2112\u201330. https:\/\/doi.org\/10.1148\/rg.220070.","journal-title":"Radiographics"},{"key":"5058_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-021-01133-z","volume":"13","author":"JA Dybvik","year":"2022","unstructured":"Dybvik JA, Fasmer KE, Ytre-Hauge S, Husby JHA, Salvesen \u00d8O, Stefansson IM, et al. MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. Insights Imaging. 2022;13:1. https:\/\/doi.org\/10.1186\/s13244-021-01133-z.","journal-title":"Insights Imaging"},{"key":"5058_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","volume":"37","author":"E Euscher","year":"2013","unstructured":"Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, et al. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013;37:1728\u201336. https:\/\/doi.org\/10.1097\/PAS.0b013e318299f2ab.","journal-title":"Am J Surg Pathol"},{"key":"5058_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1055\/s-0041-1734377","volume":"31","author":"FB Gala","year":"2021","unstructured":"Gala FB, Gala KB, Gala BM. Magnetic resonance imaging of uterine cervix: A pictorial essay. Indian J Radiol Imaging. 2021;31:454\u201367. https:\/\/doi.org\/10.1055\/s-0041-1734377.","journal-title":"Indian J Radiol Imaging"},{"key":"5058_CR16","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.3802\/jgo.2021.32.e22","volume":"32","author":"C Nwachukwu","year":"2021","unstructured":"Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, et al. Recurrence risk factors in stage IA grade 1 endometrial cancer. J Gynecol Oncol. 2021;32:e22. https:\/\/doi.org\/10.3802\/jgo.2021.32.e22.","journal-title":"J Gynecol Oncol"},{"key":"5058_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/cancers16020390","volume":"16","author":"B Dobrzycka","year":"2024","unstructured":"Dobrzycka B, Terlikowska KM, Kowalczuk O, Niklinski J, Kinalski M, Terlikowski SJ. Prognosis of stage I endometrial cancer according to the FIGO 2023 classification taking into account molecular changes. Cancers (Basel). 2024;16:390. https:\/\/doi.org\/10.3390\/cancers16020390.","journal-title":"Cancers (Basel)"},{"key":"5058_CR18","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4143\/crt.2015.356","volume":"48","author":"MS Yoon","year":"2016","unstructured":"Yoon MS, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, et al. Adjuvant treatment after surgery in stage IIIA endometrial adenocarcinoma. Cancer Res Treat. 2016;48:1074\u201383. https:\/\/doi.org\/10.4143\/crt.2015.356.","journal-title":"Cancer Res Treat"},{"key":"5058_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/IGC.0b013e3182978328","volume":"23","author":"S Kuku","year":"2013","unstructured":"Kuku S, Williams M, McCormack M. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. A single-institution retrospective study. Int J Gynecol Cancer. 2013;23:1056\u201364. https:\/\/doi.org\/10.1097\/IGC.0b013e3182978328.","journal-title":"Int J Gynecol Cancer"},{"key":"5058_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/gyno.2002.6713","volume":"86","author":"A Mariani","year":"2002","unstructured":"Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38\u201344. https:\/\/doi.org\/10.1006\/gyno.2002.6713.","journal-title":"Gynecol Oncol"},{"key":"5058_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/cancers16101869","volume":"16","author":"M Menendez-Santos","year":"2024","unstructured":"Menendez-Santos M, Gonzalez-Baerga C, Taher D, Waters R, Virarkar M, Bhosale P. Endometrial cancer: 2023 revised FIGO staging system and the role of imaging. Cancers (Basel). 2024;16:1869. https:\/\/doi.org\/10.3390\/cancers16101869.","journal-title":"Cancers (Basel)"},{"key":"5058_CR22","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/cancers16101848","volume":"16","author":"A Horala","year":"2024","unstructured":"Horala A, Szubert S, Nowak-Markwitz E. Range of resection in endometrial cancer\u2014clinical issues of made-to-measure surgery. Cancers (Basel). 2024;16:1848. https:\/\/doi.org\/10.3390\/cancers16101848.","journal-title":"Cancers (Basel)"},{"key":"5058_CR23","doi-asserted-by":"publisher","unstructured":"Li W, Jiang J, Fu Y, Shen Y, Zhang C, Yao S, et al. Implications of isolated para-aortic lymph node metastasis in endometrial cancer: A large-scale, multicenter, and retrospective study. Front Med (Lausanne). 2021;8. https:\/\/doi.org\/10.3389\/fmed.2021.754890.","DOI":"10.3389\/fmed.2021.754890"},{"key":"5058_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ygyno.2022.03.026","volume":"165","author":"LG Sapienza","year":"2022","unstructured":"Sapienza LG, Thomas JJ, Showalter TN, Echeverria AE, Ludwig MS, Chen AC, et al. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol. 2022;165:642\u201349. https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.026.","journal-title":"Gynecol Oncol"},{"key":"5058_CR25","doi-asserted-by":"publisher","first-page":"113913","DOI":"10.1016\/j.ejca.2024.113913","volume":"201","author":"N Gravbrot","year":"2024","unstructured":"Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. Eur J Cancer. 2024;201:113913. https:\/\/doi.org\/10.1016\/j.ejca.2024.113913.","journal-title":"Eur J Cancer"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05058-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:03:43Z","timestamp":1769148223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05058-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5058"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05058-9","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}